NCM
GSK icon

Northroad Capital Management’s GSK GSK Stock Holding History

Northroad Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.07M Sell
19,811
-46,759
-70% -$2.56M 2.44% 21
2016
Q2 		$3.61M Sell
66,570
-10,492
-14% -$553K 2.77% 13
2016
Q1 		$3.91M Sell
77,062
-2,760
-3% -$137K 2.53% 22
2015
Q4 		$4.03M Sell
79,822
-6,468
-7% -$330K 2.4% 21
2015
Q3 		$4.15M Sell
86,290
-4,167
-5% -$217K 2.44% 21
2015
Q2 		$4.71M Buy
90,457
+1,863
+2% +$105K 2.42% 22
2015
Q1 		$5.11M Sell
88,594
-20,723
-19% -$1.19M 2.73% 15
2014
Q4 		$5.84M Sell
109,317
-12,044
-10% -$674K 2.64% 16
2014
Q3 		$6.97M Sell
121,361
-5,797
-5% -$355K 2.69% 12
2014
Q2 		$8.5M Buy
127,158
+1,911
+2% +$129K 2.97% 8
2014
Q1 		$8.37M Sell
125,247
-2,207
-2% -$149K 3.03% 9
2013
Q4 		$8.51M Sell
127,454
-643
-0.5% -$41.7K 3.05% 10
2013
Q3 		$8.03M Sell
128,097
-6,288
-5% -$405K 3.08% 8
2013
Q2 		$8.39M Buy
+134,385
New +$8.53M 3.26% 5

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Northroad Capital Management's GSK Position: Q3 2016 in Review

Northroad Capital Management reduced its GSK (GSK) stake by 70% in Q3 2016, selling an estimated $2.56M and leaving 19,811 shares worth $1.07M. The position accounts for 2.44% of the portfolio, ranked #21.

Northroad Capital Management first reported a position in GSK in Q2 2013 and has held it in 14 quarters since. The position peaked at $8.51M in Q4 2013. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

  • Northroad Capital Management held 19,811 shares of GSK worth $1.07M as of Q3 2016.
  • Northroad Capital Management sold 46,759 GSK shares in Q3 2016, an estimated $2.56M.
  • GSK made up 2.44% of Northroad Capital Management's portfolio in Q3 2016, its #21 holding.
  • Northroad Capital Management first reported a position in GSK in Q2 2013 and has held it in 14 quarters since.
  • Northroad Capital Management's GSK position peaked at $8.51M in Q4 2013.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Northroad Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.